1
|
Pluta P, Giza A, Kolenda M, Fendler W, Braun M, Chudobiński C, Chałubińska-Fendler J, Araszkiewicz M, Loga K, Lembas L, Witkowska M, Pluta A, Kolasiński J, Basta P, Kołacińska-Voytkuv A, Cieśla S, Jesionek-Kupnicka D, Jankau J, Kuczyński M, Kalinka E, Zadrożny M, Murawa D. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in Poland: analysis of patient series and practical guidelines for breast surgeons. Arch Med Sci 2020; 19:1243-1251. [PMID: 37732037 PMCID: PMC10507758 DOI: 10.5114/aoms.2020.100637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/12/2020] [Accepted: 09/07/2020] [Indexed: 09/22/2023] Open
Abstract
Introduction Although breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is infrequent, with less than 1000 noted cases worldwide, patients consenting for breast implant surgery should be aware of its risk. We describe the first Polish multicenter case-series data on BIA-ALCL patients and present diagnostic and treatment recommendation for breast surgeons. Material and methods In cooperation with the Polish Society of Surgical Oncology and Polish Lymphoma Research Group, we collected BIA-ALCL cases in Poland. Results We retrospectively reviewed clinical data of seven BIA-ALCL patients, diagnosed between July 2013 and November 2019. The median time from implant placement to the first BIA-ALCL symptoms was 65 months (range: 33-96 months). All the patients were exposed to textured implants at presentation. Capsulectomy with implant removal was performed in all the patients with immediate reimplantation in 2 cases. In a median follow-up of 19 months (range 5-81 months), there was no recurrence and all the patients stayed alive. Between 2013 and 2019, the incidence of BIA-ALCL in Polish female population age 30 and above ranged from 0 to 0.021/100 000/year. Conclusions BIA-ALCL is scarce in the Polish population. In a short-term follow-up, patients' prognosis remains excellent. Due to the withdrawal of roughly textured implants from the market and the exclusion of likely the most potent etiologic factor, it might be expected that the incidence of BIA-ALCL will become even rarer.
Collapse
Affiliation(s)
- Piotr Pluta
- Department of Surgical Oncology and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
| | - Agnieszka Giza
- Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
| | | | - Wojciech Fendler
- Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
- Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland
| | - Marcin Braun
- Department of Radiotherapy, Military Institute of Medicine, Warsaw, Poland
| | - Cezary Chudobiński
- Department of Radiology, Regional Oncology Centre, Copernicus Memorial Hospital, Lodz, Poland
| | | | - Michał Araszkiewicz
- Legal Advisor’s Office, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
| | - Karolina Loga
- Department of Radiotherapy and General Oncology, Regional Oncology Centre, Copernicus Memorial Hospital in Lodz, Medical University of Lodz, Lodz, Poland
| | | | - Magdalena Witkowska
- Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland
| | - Agnieszka Pluta
- Department of Hematology, Medical University of Lodz, Lodz, Poland
| | | | - Paweł Basta
- Departament of Gynecology and Oncology, Jagiellonian University, Medical College Breast Unit of University Hospital, Krakow, Poland
| | | | - Sławomir Cieśla
- Clinic of General Surgery and Surgical Oncology, Faculty of Medicine and Health Sciences University, Zielona Gora, Poland
| | | | - Jerzy Jankau
- Department of Plastic Surgery, Gdansk Medical University, Gansk, Poland
| | | | - Ewa Kalinka
- Department of Oncology, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
| | - Marek Zadrożny
- Department of Surgical Oncology and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
| | - Dawid Murawa
- Clinic of General Surgery and Surgical Oncology, Faculty of Medicine and Health Sciences University, Zielona Gora, Poland
| |
Collapse
|
2
|
Gottwald L, Moszyńska-Zielińska M, Żytko L, Tomalczyk A, Loga K, Fijuth J. Prolonged retention of the Lippes loop intrauterine device as a cause of vaginal bleeding 10 years after chemoradiotherapy of locally advanced cervical carcinoma: case report and review of the literature. J OBSTET GYNAECOL 2018; 39:131-132. [PMID: 30350737 DOI: 10.1080/01443615.2018.1458080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Leszek Gottwald
- a Department of Radiotherapy , Medical University of Lodz , Lodz , Poland.,b Department of Teleradiotherapy , Regional Cancer Center, Copernicus Memorial Hospital of Lodz , Lodz , Poland
| | | | - Leszek Żytko
- b Department of Teleradiotherapy , Regional Cancer Center, Copernicus Memorial Hospital of Lodz , Lodz , Poland
| | - Adam Tomalczyk
- c Department of Imaging Diagnostics , Regional Cancer Center, Copernicus Memorial Hospital of Lodz , Lodz , Poland
| | - Karolina Loga
- a Department of Radiotherapy , Medical University of Lodz , Lodz , Poland.,d Department of Radiotherapy and General Oncology , Regional Cancer Center, Copernicus Memorial Hospital of Lodz , Lodz , Poland
| | - Jacek Fijuth
- a Department of Radiotherapy , Medical University of Lodz , Lodz , Poland.,b Department of Teleradiotherapy , Regional Cancer Center, Copernicus Memorial Hospital of Lodz , Lodz , Poland
| |
Collapse
|
3
|
Kluska A, Papis-Ubych A, Fijuth J, Loga K, Spych M, Gottwald L. Intraorbital extraocular metastasis of breast cancer 11 years after mastectomy - case report and review of the literature. J OBSTET GYNAECOL 2018; 39:126-128. [PMID: 29893150 DOI: 10.1080/01443615.2018.1455078] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Adam Kluska
- a Department of Radiotherapy and General Oncology, Regional Cancer Center , Copernicus Memorial Hospital of Lodz , Lodz , Poland.,b Department of Radiotherapy, Chair of Oncology , Medical University of Lodz , Lodz , Poland
| | - Anna Papis-Ubych
- a Department of Radiotherapy and General Oncology, Regional Cancer Center , Copernicus Memorial Hospital of Lodz , Lodz , Poland
| | - Jacek Fijuth
- b Department of Radiotherapy, Chair of Oncology , Medical University of Lodz , Lodz , Poland.,c Department of Teleradiotherapy, Regional Cancer Center , Copernicus Memorial Hospital of Lodz , Lodz , Poland
| | - Karolina Loga
- a Department of Radiotherapy and General Oncology, Regional Cancer Center , Copernicus Memorial Hospital of Lodz , Lodz , Poland.,b Department of Radiotherapy, Chair of Oncology , Medical University of Lodz , Lodz , Poland
| | - Michal Spych
- a Department of Radiotherapy and General Oncology, Regional Cancer Center , Copernicus Memorial Hospital of Lodz , Lodz , Poland.,b Department of Radiotherapy, Chair of Oncology , Medical University of Lodz , Lodz , Poland
| | - Leszek Gottwald
- b Department of Radiotherapy, Chair of Oncology , Medical University of Lodz , Lodz , Poland.,c Department of Teleradiotherapy, Regional Cancer Center , Copernicus Memorial Hospital of Lodz , Lodz , Poland
| |
Collapse
|
4
|
Włodarczyk M, Sobolewska A, Wójcik B, Loga K, Fichna J, Wiśniewska-Jarosińska M. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients. World J Gastroenterol 2014; 20:7019-7026. [PMID: 24944497 PMCID: PMC4051946 DOI: 10.3748/wjg.v20.i22.7019] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2013] [Revised: 01/25/2014] [Accepted: 03/06/2014] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the correlation between the appearance of skin lesions and concentration of interleukin (IL)-17A, IL-23 and interferon-γ (IFN-γ) in Crohn’s disease (CD) patients during anti-tumor necrosis factor-α (TNF-α) therapy
METHODS: A prospective study included 30 adult patients with CD of Caucasian origin (19 men and 11 women; mean age ± SD 32.0 ± 8.6 years) during biological therapy with anti-TNF-α antibodies from January 2012 to March 2013. Eighteen patients were treated with infliximab, seven with adalimumab and five with certolizumab. Inclusion criteria were exacerbation of the underlying disease, Crohn’s Disease Activity Index over 300 and the ineffectiveness of previously used non-biological therapies. Patients with a history of psoriasis, atopic dermatitis and other autoimmune skin lesions were excluded from the study. The control group consisted of 12 healthy subjects. A diagnostic survey was carried out, blood tests and careful skin examination were performed, and the serum levels of IL-17, IL-23 and IFN-γ were measured using an enzyme-linked immunosorbent assays technique. Dermatoses that have developed in the course of biological therapy in patients who had no pre-existing skin lesions of similar character were qualified as skin lesions induced by anti-TNF-α therapy.
RESULTS: Skin manifestations occurred in 18 of CD patients during the anti-TNF-α therapy (60%), in the average time of 10.16 ± 3.42 mo following the beginning of the 52-wk treatment cycle. Skin lesions observed in CD patients during biological therapy included psoriasiform lesions (44.4%), and eczema forms lesions (22.2%). In CD patients with drug induced skin lesions significantly higher levels of hemoglobin (13.3 ± 1.5 g/dL vs 10.8 ± 1.9 g/dL, P = 0.018) and hematocrit (39.9% ± 4.5% vs 34.3% ± 5.4%, P = 0.01), as well as a significantly lower level of platelets (268 ± 62 × 103/μL vs 408 ± 239 × 103/μL, P = 0.046) was observed compared with CD patients without skin manifestations. The concentrations of IL-17A and IL-23 in CD patients with skin lesions developed under anti-TNF-α therapy were significantly higher compared to those in patients without lesions (IL-17A: 39.01 ± 7.03 pg/mL vs 25.71 ± 4.90 pg/mL, P = 0.00004; IL-23: 408.78 ± 94.13 pg/mL vs 312.15 ± 76.24 pg/mL, P = 0.00556).
CONCLUSION: Skin lesions in CD patients during biological therapy may result from significantly increased concentrations of IL-17A and IL-23, which are strongly associated with TNF-α/Th1 immune pathways.
Collapse
|